title: Targeting the intratumor heterogeneity in PMBL.
authors.affiliation: a Institute of Pathology; University Ulm; Ulm, Germany.
authors.forename: Olga
authors.initials: O
authors.lastname: Ritz
authors.forename: Peter
authors.initials: P
authors.lastname: Möller
authors.forename: Alexey
authors.initials: A
authors.lastname: Ushmorov
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D018740:Genetic Heterogeneity; D006801:Humans; D016393:Lymphoma, B-Cell / Q000235:genetics* / Q000628:therapy*; D008479:Mediastinal Neoplasms / Q000235:genetics* / Q000628:therapy*; D009857:Oncogenes; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D055502:Secondary Prevention; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
keywords: BCL6; immunochemotherapy; oncogenic programs; pSTAT6; sensitization